“NANOPARTICLE-BASED TARGETED DRUG DELIVERY FOR THE TREATMENT OF HEMATOLOGICAL DISORDERS” (2025) Journal of Medical & Health Sciences Review, 2(2). doi:10.62019/762rmz59.